Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05881759 · ClinicalTrials.gov registry record · NA
Integrating Food Rx With Best Feeding Practices With EFNEP
A NA study of Childhood Obesity and Dietary Habits, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 375
- Enrollment target
- 1
- Study location
NCT05881759: Recruiting NA study of Childhood Obesity and Dietary Habits, sponsored by Baylor College of Medicine.
NCT05881759 is a NA study of Childhood Obesity and Dietary Habits that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 375 participants, below the 552-participant average among 43 other Childhood Obesity trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05881759, a NA study of Childhood Obesity and Dietary Habits, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 375 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess feasibility and acceptability of of integrating Food Rx and Best Feeding Practices with EFNEP participants via a pilot study.
Primary Outcome
Feeding practices will be assessed using the Food Parenting Inventory
Conditions Studied
Interventions
- BEHAVIORAL BEST study - Nutrition education only
- BEHAVIORAL BEST study - Nutrition education and feeding practices
- BEHAVIORAL BEST study - Nutrition education, feeding practices, and Food Rx
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT05881759 shows while recruiting
NCT05881759 is an interventional study that assigns participants to a tested intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap, below the 552-participant average among 43 other Childhood Obesity trials with a reported enrollment target (32% lower).
The record links to 4 conditions, with Childhood Obesity appearing as the primary indexed condition, and to 3 interventions - of which BEST study - Nutrition education only is the first listed.
NCT05881759 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05881759 about?
NCT05881759 is a clinical study titled "Integrating Food Rx With Best Feeding Practices With EFNEP". To assess feasibility and acceptability of of integrating Food Rx and Best Feeding Practices with EFNEP participants via a pilot study.
What is the current status of trial NCT05881759?
This trial is currently recruiting. It is a NA study. The enrollment target is 375 participants. The study started on 2024-01-15. Estimated completion is 2026-03-31.
What conditions does trial NCT05881759 study?
This clinical trial studies the following conditions: Childhood Obesity, Dietary Habits, Food Selection, Feeding Behavior.
What interventions are being tested in trial NCT05881759?
The interventions under investigation include: BEST study - Nutrition education only (BEHAVIORAL), BEST study - Nutrition education and feeding practices (BEHAVIORAL), BEST study - Nutrition education, feeding practices, and Food Rx (BEHAVIORAL).
Who is sponsoring clinical trial NCT05881759?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05881759 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05881759's enrollment target sits among peer trials
375 13th of 43 higher than 31 of 43 other Childhood Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Childhood Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Family Intervention to Prevent Childhood Obesity
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
Genetic Risk, Parental Feeding Practices, and Appetitive Traits in Early Life
RECRUITING · NA
-
Maternal Smoking Cessation and Pediatric Obesity Prevention
RECRUITING · NA
-
Mountain West Prevention Research Center Core Research Project
RECRUITING · NA
-
The Dose Trial: Dose Intensity of Behavioral Interventions for Childhood Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI